Comparative proteomic analysis of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma by Suzuki, Tadaki et al.
MEETING ABSTRACT Open Access
Comparative proteomic analysis of cancer stem
cells in a Tax-transgenic (Tax-Tg) mouse model of
adult T-cell leukemia/lymphoma
Tadaki Suzuki
1, Akiko Okayama
2, Takahiro Tsuji
1, Akihide Ryo
3, Hisashi Hirano
2, Tetsutaro Sata
1, William W Hall
4,
Hideki Hasegawa
1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Adult T-cell leukemia (ATL) is a T-cell malignancy
caused by HTLV-1. In ATL, chemotherapeutic
responses are generally poor, which has suggested the
existence of chemotherapy-resistant cancer stem cells
(CSCs). The HTLV-I transactivator, Tax, initiates ATL-
like disease (mATL) in Tax transgenic mice. Recently,
the CSCs of mATL were identified. The CSCs in a side
population, could consistently regenerate the original
lymphoma and overlapped with a minor population of
CD38(-)/CD71(-)/CD117(+) cells, suggesting that the
eradication of cancer stem cells will be necessary to
improve the outcome of treatment for mATL. In design-
ing specific regimens for CSCs, antibody-based therapy
appears to be a promising way to destroy CSCs. A small
number of target antigens on cancer stem cells have
been described. It remains to be determined, however,
whether these and other targets will distinguish cancer
stem cells from normal tissues.
In this study, a proteomic approach was used to iden-
tify proteins differentially expressed in CSCs of mATL.
The CSCs of mATL were isolated using cell sorting, and
analyzed by label-free LC-MS/MS to compare protein
profiles in CSCs and no-CSCs. More than 700 proteins
were detected. The levels of 53 proteins were increased
in CSCs. An interesting finding is that these proteins
included one membrane protein, which might poten-
tially serve as a new target of antibody-based therapy.
Flow cytometry validated expression of the membrane
protein. Taken together, the data presented provide a
significant new protein-level insight into the biology of
cancer stem cells of mATL, a key population which are
involved in mATL development.
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